Stephen Chang is a scientist and entrepreneur with over 30 years of experience in gene and cell therapy. Brett Johnson: Can you tell us a bit about your background in the field […]
INTERVIEW: Renowned Geneticist Stephen Chang
INTERVIEW: Travera CEO Clifford Reid PhD
Clifford Reid is the founding CEO of Travera. Previously, Dr. Reid was the founding Chairman, President and Chief Executive Officer of Complete Genomics (NASDAQ:GNOM), a leading developer of whole human genome DNA […]
INTERVIEW: Soligenix CEO Christopher Schaber PhD.
Dr. Christopher Schaber, President and CEO of Soligenix, a company developing drug therapies in rare diseases and areas of unmet medical need, including a treatment for oral mucositis in head and neck […]
INTERVIEW: Biden Cancer Initiative’s Greg Simon
Greg Simon is the president of the Biden Cancer Initiative, formerly called The Cancer Moonshot, the goal was to try to make ten years of progress in five years. It was kicked […]
INTERVIEW: International Cancer Impact Fund founder Bill Werkmeister
After graduating from Cornell, William Werkmeister started his career as an investment banker at Salomon Smith Barney and Citigroup and then worked for a series of state-sponsored venture capital funds that supported […]
Phillip Polakoff MD on the Biggest Challenges in Health and the delivery of healthcare in the U.S.A and worldwide
Phil Polakoff who has been engaged in the healthcare field for over 35 years, offers a unique perspective on where we are and where we are going. Brett Johnson: Phil, what do […]
ImmunoCellular Therapeutics’ Immune-Based Therapies for the Treatment of Cancer
Dr. Anthony Gringeri, President and CEO of Immunocellular Therapeutics, a company developing immune-based therapies for the treatment of cancer, is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells […]
Glynn Wilson – CEO of TapImmune on Vaccines for Cancer
Immunotherapy is the future of cancer treatment and TapImmune has been leading the charge. CEO Glynn Wilson discusses the advances made in the ovarian and breast cancer. The company is taking a […]
